手机扫码接着看

50freespinsnodepositrequired| CITIC Securities: Positive factors accumulate and optimism is sprouting

Author:editor|Category:Entertainment

Securities Times online news50freespinsnodepositrequiredThe latest strategy report of CITIC Securities (600030) points out that the macro policy environment is constantly improving, many positive factors are accumulating, all kinds of funds rush to promote the comprehensive repair of Chinese assets in the near future, optimism is budding, and the market has returned to normal. It is suggested to play down the game and focus on the three main lines of performance growth, low-wave dividend and active theme in allocation.

First of all, judging from the recent intensive positive factors, first, the tone of real estate policy has changed significantly, and the predicament of the industrial chain is expected to be reversed; second, the market has entered a performance vacuum in the short term, and the performance in the first quarter is expected to be the annual low; third, some industry policies have begun to focus on production control and price protection, improving the competitive pattern and corporate profitability; fourth, the logic of going out to sea has been widely recognized by the market, opening the growth and valuation ceiling of traditional industries. Secondly, from the perspective of the incremental capital structure of the market, the rapid increase of private equity positions and the intensive inflow of northward trading funds have brought increments to A shares, while southward capital inflows and rebalancing of foreign investment in Asia-Pacific have accelerated the development of Hong Kong stocks. Finally, from the perspective of the ecology of the market, investors have emerged from the atmosphere of excessive caution, and the normalization of IPO also marks a return to normal.

Proofread: Zhu Tian Ting

50freespinsnodepositrequired| CITIC Securities: Positive factors accumulate and optimism is sprouting

12 05

2024-05-12 21:45:03

浏览43
Back to
Category
Back to
Homepage
crashbandicoot3online| Yahong Pharmaceutical: The marketing application for hexylamevulinate hydrochloride ointment photodynamic therapy system was accepted onlineholdem| Microcore Biotech (688321.SH): Application for the III clinical trial of cidabenide in the treatment of colorectal cancer accepted